Acorda Therapeutics | ACOR - Le Chiffre D'Affaires De Vente



Ventes Changement Date
Acadia Pharmaceuticals USD 284M 5.4M 2025-12
Agios Pharmaceuticals USD 19.97M 7.07M 2025-12
ALKERMES USD 384.5M 9.7M 2025-12
Alterity Therapeutics Limited AUD 11.38K 10.23K 2022-12
Amgen USD 9.9B 340M 2025-12
Anika Therapeutics USD 30.62M 2.8M 2025-12
Arrowhead Research USD 264.03M 7.56M 2025-12
Biogen USD 2.28B 250M 2025-12
BioMarin Pharmaceutical USD 875M 99M 2025-12
Cara Therapeutics USD 2.57M 1.11M 2025-03
Cipla INR 75.18B 710M 2025-12
Clal Biotechnology ILS 3.41M 2M 2022-12
Compugen USD 67.33M 65.44M 2025-12
CSL USD 8.33B 4.79B 2025-12
Cytokinetics USD 17.76M 15.83M 2025-12
Enanta Pharmaceuticals USD 16.96M 50.68M 2024-12
Gilead Sciences USD 7.93B 130M 2025-12
GlaxoSmithKline GBP 8.62B 73M 2025-12
Grifols EUR 2.34B 33.3M 2026-03
Halozyme Therapeutics USD 451.76M 97.76M 2025-12
Heron Therapeutics USD 40.59M 2.38M 2025-12
Insmed USD 263.8M 121.8M 2025-12
Ligand Pharmaceuticals USD 59.66M 55.8M 2025-12
MannKind USD 111.96M 29.83M 2025-12
Merck EUR 5.25B 70M 2025-12
Moderna USD 678M 342M 2025-12
Neurocrine Biosciences USD 805.5M 10.6M 2025-12
Novartis USD 13.86B 50M 2025-12
Pfizer USD 17.58B 880M 2025-12
Sanofi EUR 11.3B 1.13B 2025-12
Teva Pharmaceutical Industries USD 14.63B 10M 2025-12
Ultragenyx Pharmaceutical USD 207M 47M 2025-12
Vertex Pharmaceuticals USD 3.19B 110M 2025-12